Page 1581 - Small Animal Internal Medicine, 6th Edition
P. 1581

Index  1553


            Chronic kidney disease (CKD)   Cinefluoroscopy, 451  Computed tomography pulmonary   Congestive heart failure (CHF)
               (Continued)            Circling, 1046, 1046f       angiography, 355–356      (Continued)
             cardiovascular complications of, 698  Circulating neutrophil pool, 1372  Concentric myocardial hypertrophy, 105  fulminant, 61
  VetBooks.ir  causes of, 692b        Cisternal puncture, for cerebrospinal   within atrioventricular mode, 43–44,   general considerations for, 66
                                                               Conduction disturbances
                                                                                           furosemide for, 64t, 66–67, 128
             in cats, 692b, 693t
                                      Cisapride, 440–441, 455–456, 515t–517t
             clinical findings of, 698
                                        fluid collection, 1069–1070, 1070f
                                                                    44f
                                                                                           hydralazine for, 71
             clinicopathologic findings of, 698–702
             course of, 702           Citrate intoxication, 1358  electrocardiography of, 42–45  hyponatremia in, 74
                                      Clavamox. see Amoxicillin-clavulanate
                                                                 intraventricular, 44
                                                                                           infective endocarditis as cause of, 132
             in dogs, 692b, 693t      Cleansing enemas, 445      left bundle branch block, 44  inotropic support, 63–65
             external solute balance, 694–695, 695f  Cleft palate, 1015f–1017f  right bundle branch block, 44, 45f  left-sided, 1, 110
             familial, 693b           Clindamycin, 386t–388t, 515t–517t,   ventricular preexcitation, 44–45, 45f  description of, 1, 110
             gastrointestinal disturbances in,   1127–1128, 1185t–1186t,   Congenital ductal plate abnormalities,   edema caused by, 291
                697–698                 1437t–1438t, 1443, 1521   611                      loop diuretics for, 66–67
             hemostatic defects in, 697  Clomipramine, 728b    Congenital esophageal weakness,   mild to moderate, 128–129
             hypertension in, 698     Clopidogrel                 452–454, 453f            monitoring of, 73–74, 74b
             hyperthyroidism and, 696f, 698,   for arterial thromboembolism  Congenital heart disease, 100–118  nitrates for, 71–72
                790–791                 in cats, 226–228, 227b   atrioventricular septal defect, 100  noncardiac conditions of, 3
             imaging of, 698–702        in dogs, 232             atrioventricular valve malformation,   pericardial effusion associated with,
             metabolic acidosis of, 697  immune-mediated diseases treated   112–113          176
             metabolic complications of, 698  with, 1255t–1256t  in cats, 100              pimobendan for, 63, 64t, 69, 128
             pathophysiology of, 693–698, 693b  Cloprostenol, 955–956, 960, 1034t–1036t  cor triatriatum, 117  prazosin for, 71
             prognosis for, 702       Clostridial colitis, 494   in dogs, 102t             reevaluations, 73–74
             progression of, 698–699  Clostridial disease, 482, 482f  endocardial fibroelastosis, 100, 117  refractory, 74–75, 127b, 129–130, 147,
             proteinuria in, 681, 681b  Clostridium spp., 1427–1428  extracardiac arteriovenous shunt,   167
             staging of, 692           acute hemorrhagic diarrheal syndrome   101–105      right-sided, 142, 171, 181, 186–187
             supportive care for, 702     and, 462               general considerations, 100  fluid accumulation in, 6
             treatment of, 699–702, 699b  C. botulinum, 1169     intracardiac shunt, 109–112  heartworm disease as cause of,
               anabolic steroids, 702  C. perfringens, 1427–1428, 1440t, 1442  mitral dysplasia, 102t–103t, 112  202–203, 206
               angiotensin receptor blockers, 701  C. tetani, 1181  murmurs caused by, 100  jugular vein distention and, 5, 5f
               angiotensin-converting enzyme   Clotrimazole      noninvasive testing for, 100  salt restriction for, 72, 128–129
                 inhibitors, 701       complications of, 263     patent ductus arteriosus. see Patent   severe, 129
               antiemetics, 701        nasal aspergillosis treated with,   ductus arteriosus  spironolactone for, 67
               blood pressure control agents, 702  261–263, 262f  pulmonary hypertension with shunt   supplemental oxygen for, 61
               calcitriol, 702        Clotting factors              reversal, 114–116, 115f  thiazide diuretics for, 67
               dietary management, 699–702  defects of, 1393b    pulmonic stenosis. see Pulmonic   treatment of, 61–66, 129, 146b
               endocrine replacement therapy,   deficiency of, 1356, 1399–1400  stenosis   vasodilators for, 61–63, 64t, 129
                 701–702               description of, 1387      radiographic findings, 103t  Congestive signs, of heart failure, 1, 2b
               erythropoietin, 701–702  Cluster seizures, 1095   subaortic stenosis. see Subaortic   Congestive splenomegaly, 1412t
               general principles, 699  Coagulation cascade, 222, 1387–1388,   stenosis  Conn’s syndrome, 892–893
               H 2  receptor antagonists, 701  1391f             tetralogy of Fallot. see Tetralogy of   Consciousness, disorders of, 1043t
               phosphorus restriction, 700–701  Coagulation tests, 543  Fallot           Constant-rate infusion, 88b
            Chronic leukemias         Coagulopathies, 527–529, 529b  tricuspid dysplasia, 102t–103t,   Constipation, 404–405, 404b, 506–507
             in cats, 1320–1321, 1321f  treatment of, 594–595       112–113                dietary indiscretion leading to, 507
             in dogs, 1316–1319       Coarse wheat bran, 445t    vascular ring anomalies, 116–117  Constrictive pericardial disease, 184–185
               chemotherapy for, 1319b  Cobalamin, 423–424, 1364, 1364f  ventricular outflow obstruction,   Continuous glucose-monitoring systems,
               clinical features of, 1317  Coccidians, 1537–1538, 1537f  105–109            821, 822f
               diagnosis of, 1318–1319  Coccidioides immitis, 1505, 1506f  ventricular septal defect. see   Continuous (machinery) murmurs, 9–11
               hematologic features of, 1317–1318,   Coccidioides spp., 1503t  Ventricular septal defect  Continuous wave Doppler
                 1317f–1318f          Coccidioidomycosis, 1505–1507  Congenital hypothyroidism, 1032–1033,   echocardiography, 30, 31f
               prevalence of, 1316    Coccidiosis, 488, 1028      1033f                  Contrast echocardiography, 27, 28f
               treatment of, 1319     Codman triangle, 1326    Congenital infertility, 1005  Contrast-enhanced gastrograms, 422
            Chronic lymphocytic leukemia, 1312t  Colace. see Dioctyl sodium   Congenital portosystemic shunt,   “Convulsive syncope,”, 1–2
             blood smear findings, 1321f  sulfosuccinate          603–609                Coombs test, 1216, 1216b
             differential diagnosis of, 1379  Colchicine         clinical features of, 604, 604f  Coonhound paralysis, 1166
            Chronic myeloid leukemia, 1312t  joint disease treated with, 1209t–1210t  diagnosis of, 604–605, 604f  Copper storage disease, 595–598
            Chronic neutrophilic cholangitis, 568t  serum amyloid A protein release   etiology and pathogenesis of, 603  clinical features of, 595–596, 596f
            Chronic pancreatitis          affected by, 683–684   hepatic encephalopathy in, 606–608,   diagnosis of, 596–597, 596f
             acute pancreatitis versus, 623t  Collapse, 1–2         607b                   etiology of, 595
             autoimmune, 634           disorders causing, 1183–1184  prognosis for, 605–606, 605f  feline, 576
             biopsy of, 636            exercise-induced, 1183–1184  treatment for, 605–606  pathogenesis of, 595
             clinical features of, 635  Collapsing trachea. see Trachea, collapse   Congenital portosystemic shunts,   treatment of, 597–598, 597b
             definition of, 633         of                        577–579, 578f          Copulatory lock, 940f
             description of, 620      Colloids, 433            Congenital vascular disorders, 603–612  Cor triatriatum, 117
             diagnosis of, 635–636    Colonoscopy, 405, 427, 429f  Congenital vestibular syndromes, 1114  Corneal ulcers, 258
             etiology of, 633–634     Color flow mapping, 31–32, 31f–32f  Congestive heart failure (CHF). see also   Coronary artery thromboembolism,
             idiopathic, 634, 634f    Coma, 1043                  Heart failure             231
             pathogenesis of, 633–634  Combined cytopenias, 1381–1386  acute, 65, 129–130, 145  Coronaviral enteritis
             prognosis for, 636        bone marrow aplasia-hypoplasia,   amlodipine for, 71  canine, 479
             signs of, 635                1384–1385              angiotensin-converting enzyme   feline, 479
             treatment of, 636         classification of, 1381      inhibitors for, 67–68  Coronavirus, feline, 1488–1491
            Chronic renal disease, 654t–655t  clinicopathologic features of,   arterial thromboembolism as cause of,   clinical features of, 1488–1489
            Chronic vestibulovaginitis, 980–982,   1381–1386        225                    diagnosis of, 1489–1490
               980f–982f               definition of, 1381–1386  benazepril for, 68        enteric, 1488
            Chyle, 362f, 363, 374     Community-acquired pneumonia, 340,   captopril for, 64t, 68  epidemiology of, 1488
            Chylomicron test, 910–911   1441t                    in cats, 164–167, 166b    etiology of, 1488
            Chylomicrons, 908, 911–912  Compazine. see Prochlorperazine  causes of, 59t    prevention of, 1491
            Chylothorax, 363, 374–375, 375b  Complete blood count, 538  corticosteroid-associated, 171–172  treatment of, 1490–1491
            Chylous pleural effusions, 361t, 362f, 363  alimentary tract disease, 405–406, 412  decompensated, 62b, 129  zoonotic aspects of, 1491
            Chymase, 120               hemoglobin assessment using, 318  dietary considerations for, 72–73  Corticosteroid(s)
            Ciba. see Terbutaline     Computed tomography (CT)   digoxin for, 69–70        congestive heart failure secondary to,
            Cicatrix                   cardiac, 18               dilated cardiomyopathy as cause of,   171–172
             description of, 424–425   larynx and pharynx, 273      146b                   fever of unknown origin treated with,
             esophageal, 459–460       lower respiratory tract disorders,   diuretics for, 66–67  1426
            Ciliary dyskinesia, 326       295–296                in dogs, 3, 285           hemolytic anemia treated with, 1349
            Ciliates, 1538–1539        nasal imaging using, 250, 250f  drug therapy for, 64t  idiopathic pulmonary fibrosis treated
            Cimetidine, 439            neuromuscular system, 1066, 1067f  enalapril for, 68  with, 351
   1576   1577   1578   1579   1580   1581   1582   1583   1584   1585   1586